Page 6,777«..1020..6,7766,7776,7786,779..6,7906,800..»

Ground broken on new facilities aimed at treating brain injuries

Posted: Published on June 14th, 2012

FORT BELVOIR, Va. Air Force Master Sgt. Earl Covel had gone through just about every treatment anyone could think of for the brain injuries he sustained over his 12 deployments even the hyberbaric chamber. Nothing seemed to be working very well. They were just throwing spears, doing the best they could, he said. Then a friend told him about the National Intrepid Center of Excellence at Bethesda, Md., a facility dedicated to the treatment, diagnosis and research of mild traumatic brain injury and psychological health issues. Covel was assigned an army of providers, he said, and his wife was encouraged to participate in the process. The team led Covel off a very dark path, he said. But while hundreds of thousands of combat veterans are suffering from brain injuries, the NICoE can only treat about 250 servicemembers a year. To help fill the gap, the Intrepid Fallen Heroes Fund, which funded and built the NICoE, has embarked on a $100 million fundraising campaign to build at least nine NICoE satellite centers at bases around the country. On Wednesday, officials broke ground on the first two at Fort Belvoir near Washington and at Camp Lejeune in North Carolina. The satellite centers … Continue reading

Posted in Brain Injury Treatment | Comments Off on Ground broken on new facilities aimed at treating brain injuries

Brain injury tied to malaria drug, doctor says

Posted: Published on June 14th, 2012

http://www.armytimes.com/news/2012/06/military-brain-injury-tied-to-malaria-drug-doctor-says-061312/ An Army physician who spent his career studying the malaria drug mefloquine, also known as Lariam, asked Congress on June 6 to support research on brain injuries he says can be caused by the medication. Speaking before the Senate Appropriations Committee, Maj. Remington Nevin requested funding for a mefloquine research center at a civilian medical or public health school to investigate the physiology, epidemiology, clinical diagnosis and treatment of health issues related to mefloquine. Given our research commitments to post-traumatic stress and traumatic brain injury this observation calls for a similarly robust agenda into mefloquine neurotoxic brain injury to ensure that patients with these conditions are receiving accurate diagnoses and the very best medical care, Nevin said. An epidemiologist and preventive medicine expert, Nevin published a case study in March of a sailor who developed psychosis, short-term memory loss, confusion and personality change after taking mefloquine. Nevin believes the drug caused lesions to form in the patients brain stem. He has published previous work similarly raising concerns about mefloquine, developed under the Armys malaria drug discovery program from 1963 to 1976 to prevent and treat malaria. Anecdotal reports of severe mefloquine reactions abound, including one presented in May at … Continue reading

Posted in Brain Injury Treatment | Comments Off on Brain injury tied to malaria drug, doctor says

Stem cell scientist wins award

Posted: Published on June 14th, 2012

13 June 2012 Last updated at 08:31 ET Japanese stem cell scientist Dr Shinya Yamanaka has been awarded the Millennium Technology Prize. His award is for discovering how to reprogram human cells to mimic embryonic stem cells, which can become any cell in the body. Called induced pluripotent stem (iPS) cells, these now aid research into regenerative medicine. He was joint-winner with Linus Torvalds, who created a new open source operating system for computers. This is the first time the prize has been shared by two scientists - they will split the 1.2m euros ($1.3m; 800,000) award. My goals over the decade include to develop new drugs to treat intractable diseases by using iPS cell technology and to conduct clinical trials using it on a few patients with Parkinson's diseases, diabetes or blood diseases. The President of the Republic of Finland, Sauli Niinisto, presented the prize at the Finnish National Opera in Helsinki. Dr Ainomija Haarla, President of Technology Academy Finland - the foundation which awards the prize every two years - said: "The International Selection Committee has to judge whether an innovation has had a favourable impact on people's lives and assess its potential for further development to benefit … Continue reading

Posted in Stem Cell Research | Comments Off on Stem cell scientist wins award

Linus Torvalds Splits Tech's 'Nobel' With Stem Cell Pioneer

Posted: Published on June 14th, 2012

Linus Torvalds. Photo: Jon Snyder/Wired Question: What do Linux and stem cell research have in common? Answer: Theyre both considered life-enhancing technical innovations by the Technology Acadamy Finland, a foundation that is awarding a prestigious award called the Millennium Technology Prize in Helsinki today. Linux creator Linus Torvalds and stem cell pioneer Shinya Yamanaka are joint recipients of the 2012 prize, an honor that some call the tech equivalent of the Nobel Prize. That means they will split the 1.2 million ($1.5 million) prize money 50-50. Torvalds and Yamanaka were named as a finalists for the prize back in April, but it was assumed that one or the other would be singled out as a grand-prize winner. The joint award comes as a bit of a surprise. Other notable scientists, including Tim Berners-Lee, have won the prize since it was created in 2002, but this is the first time judges have made a joint award. The prize is awarded every two years. Yamanaka, a Gladstone Institutes researcher affiliated with the University of California, San Francisco, has developed a technique for developing stem cells that does not require the controversial practice of harvesting embryonic stem cells. Dr. Shinya Yamanakas discovery of … Continue reading

Posted in Stem Cell Research | Comments Off on Linus Torvalds Splits Tech's 'Nobel' With Stem Cell Pioneer

Fluidigm Introduces the C1™ Single-Cell AutoPrep System to Researchers at ISSCR – Starts Early Access Program

Posted: Published on June 14th, 2012

SOUTH SAN FRANCISCO, Calif. & YOKOHAMA, Japan--(BUSINESS WIRE)-- Fluidigm (FLDM) today unveiled the details of its new C1 Single-Cell AutoPrep System to attendees at the International Society for Stem Cell Research (ISSCR) meeting in Yokohama, Japan. The C1 System, based on Fluidigms innovative microfluidic technology, enables a researcher to isolate and process individual cells rapidly and reliably for genomic analysis. For the first time, a researcher can isolate cells, extract RNA, and then reverse transcribe and preamplify mRNA transcripts automatically to enable detection and analysis of cell activity. Fluidigm has become a leader in the emerging field of single-cell genomics with its widely adopted BioMark and BioMark HD Systems, enabling scientists to routinely examine previously unavailable genomic signatures generated from a single cell. The stem cell research community in Japan, and indeed around the world, has been an important early customer group exploring single cells. Stem cell, cancer and immunology research are expected to be the initial focus applications for the C1 System. As part of its activities at ISSCR, Fluidigm also announced the start of its Early Access Program for the C1 System. The C1 System has been specifically designed to work seamlessly with the BioMark HD System to … Continue reading

Posted in Stem Cell Research | Comments Off on Fluidigm Introduces the C1™ Single-Cell AutoPrep System to Researchers at ISSCR – Starts Early Access Program

Powerful new method to analyze genetic data

Posted: Published on June 14th, 2012

ScienceDaily (June 12, 2012) University of Texas Medical Branch at Galveston researchers have developed a powerful visual analytical approach to explore genetic data, enabling scientists to identify novel patterns of information that could be crucial to human health. The method, which combines three different "bipartite visual representations" of genetic information, is described in an article to appear in the Journal of the American Medical Informatics Association. The work won a distinguished paper award when it was presented at the AMIA Summit on Translational Bioinformatics in March 2012. In the paper, the authors use their technique to analyze data on genetic alterations in humans known as single-nucleotide polymorphisms, or SNPs. Among other things, the frequencies of particular SNPs are associated with an individual's ancestral origins; for the study, the researchers chose to examine SNP data from 60 individuals from Nigeria and 60 individuals from Utah. "We selected SNPs that we already knew differentiated between the two groups, and then showed that our method can reveal more about the data than traditional methods," said UTMB associate professor Suresh Bhavnani, lead author on the JAMIA paper and a member of UTMB's Institute for Translational Sciences. "This is a fresh way of looking at … Continue reading

Comments Off on Powerful new method to analyze genetic data

Genetic Discovery Will Help Fight Diarrhoea Outbreaks

Posted: Published on June 14th, 2012

Main Category: GastroIntestinal / Gastroenterology Also Included In: Genetics Article Date: 13 Jun 2012 - 16:00 PDT Current ratings for: 'Genetic Discovery Will Help Fight Diarrhoea Outbreaks' Published today in the journal Evolutionary Applications, the findings pave the way for a new gold standard test to distinguish between the waterborne parasite's two main species affecting humans. One species is spread from person to person (Cryptosporidium hominis) but the other is often spread from livestock to people (Cryptosporidium parvum). "Being able to discriminate quickly between the two species means it is easier to spot an outbreak as it develops, trace the original source, and take appropriate urgent action to prevent further spread," said lead author Dr Kevin Tyler of Norwich Medical School at UEA. Cryptosporidium is a protozoan parasite that causes outbreaks of diarrhoea across the globe. In the UK, around two per cent of cases of diarrhoea are caused by the organism and many people will be infected at some time in their lives. Symptoms include watery diarrhoea, stomach pain, nausea and vomiting and can last for up to a month, but healthy people usually make a full recovery. However, in the developing world infection can be serious in malnourished … Continue reading

Comments Off on Genetic Discovery Will Help Fight Diarrhoea Outbreaks

Leaders in Personalized Medicine to Discuss Clinical and Market Access Challenges at 4th Annual Personalized Medicine …

Posted: Published on June 14th, 2012

MINNEAPOLIS--(BUSINESS WIRE)-- The worlds leading experts in the field of personalized medicine are meeting in Boston, MA September 12th and 13th 2012 for the 4th Annual Personalized Medicine Conference. This conference will tackle the issues driving, as well as restraining, the clinical delivery of personalized medicine, including coding and reimbursement, whole genome sequencing in practice, the economics of personalized medicine, Medicare policy, and market access challenges for companion diagnostics. Personalized medicine has the potential to revolutionize medical care by utilizing an improved understanding of genetics and molecular biology to allow for better, more precise diagnostic tests, greater predictability of disease course, and improved patient safety. Speakers and panelists will be answering the following key questions: Is personalized medicine changing clinical practice? Can personalized medicine improve clinical outcomes? Will insurers fund the genomic revolution? What types of validation requirements are payors looking for? At this conference, Robert C. Green, MD, MPH, Director, G2P Research Program, Associate Director for Research, Partners Center for Personalized Genetic Medicine, Brigham and Women's Hospital and Harvard Medical School will discuss the impact that whole genome sequencing will have on the practice of medicine, patients, and health care costs, as well as the potential risks associated with … Continue reading

Comments Off on Leaders in Personalized Medicine to Discuss Clinical and Market Access Challenges at 4th Annual Personalized Medicine …

Genetic discovery will help fight diarrhea outbreaks

Posted: Published on June 14th, 2012

Public release date: 13-Jun-2012 [ | E-mail | Share ] Contact: Simon Dunford s.dunford@uea.ac.uk 44-160-359-2203 University of East Anglia Researchers at the University of East Anglia (UEA) have discovered unexpectedly large genetic differences between two similar species of the pathogenic Cryptosporidium parasite. Published today in the journal Evolutionary Applications, the findings pave the way for a new gold standard test to distinguish between the waterborne parasite's two main species affecting humans. One species is spread from person to person (Cryptosporidium hominis) but the other is often spread from livestock to people (Cryptosporidium parvum). "Being able to discriminate quickly between the two species means it is easier to spot an outbreak as it develops, trace the original source, and take appropriate urgent action to prevent further spread," said lead author Dr Kevin Tyler of Norwich Medical School at UEA. Cryptosporidium is a protozoan parasite that causes outbreaks of diarrhoea across the globe. In the UK, around two per cent of cases of diarrhoea are caused by the organism and many people will be infected at some time in their lives. Symptoms include watery diarrhoea, stomach pain, nausea and vomiting and can last for up to a month, but healthy people usually … Continue reading

Comments Off on Genetic discovery will help fight diarrhea outbreaks

Abunda to try stem cell therapy for mom

Posted: Published on June 14th, 2012

MANILA, Philippines -- "The Buzz" host Boy Abunda is going to Europe this weekend with his mother, who is suffering from dementia and Alzeimers disease. In an interview with ABS-CBN News on Tuesday afternoon, Abunda said he will bring his mother to Germany to try stem cell therapy. "Ako ay pupunta sa Europe hindi para magbakasyon. Dadalhin ko po ang aking ina para magpagamot sa Germany. Ito po 'yung fresh stem cell therapy. Maganda 'yung dini-diretso na dahil napag-uusapan ito," Abunda said. While Abunda is in Germany, Kris Aquino will take his place on ABS-CBN's entertainment talk show "The Buzz." In the interview, Abunda also said he's proud of Aquino, who's now open to doing extreme adventures, while continuing to be a good mother to her two sons. "Ang daming nagbago kay Kris. May mga bagay na hindi ko inakala na gagawin ni Kris like 'yung diving, zipline at marami pang iba. Natutuwa ako that she has become more open to many things. She has become more adventurous. She has retained being the doting mother that she is pero mas malalim ang halakhak niya ngayon sa buhay. She's just so joyful. Natutuwa ako habang pinapanood ko ang kanyang adventure sa … Continue reading

Comments Off on Abunda to try stem cell therapy for mom

Page 6,777«..1020..6,7766,7776,7786,779..6,7906,800..»